Back to News
Market Impact: 0.8

Amprius Technologies Signals Electrifying Growth in 2026

AMPXNDAQ
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst InsightsTechnology & InnovationAutomotive & EVShort Interest & Activism
Amprius Technologies Signals Electrifying Growth in 2026

Amprius Technologies (AMPX) reported robust Q3 results, with revenue surging 172% year-over-year to $21.43 million, significantly outperforming consensus estimates by 3,000 basis points. The company demonstrated improved gross margins and a narrowed GAAP EPS loss, driven by surging demand for its silicon-anode lithium-ion batteries and an effective contract manufacturing model supporting triple-digit growth potential. Its backlog increased 83% sequentially to $53.3 million, and the customer base more than doubled, indicating strong market penetration. Analysts reacted positively, reaffirming Buy ratings and increasing price targets, while institutional accumulation and high short interest suggest potential for further stock appreciation.

Analysis

Amprius Technologies (AMPX) reported robust Q3 results, with revenue surging 172% year-over-year to $21.43 million, significantly outperforming consensus estimates by 3,000 basis points. The company demonstrated strong operational improvements, including a 600 basis point gross margin increase and a narrowed GAAP EPS loss that was three cents better than expected. This performance was driven by surging demand for its silicon-anode lithium-ion batteries and an effective contract manufacturing model. Key growth indicators include an 83% sequential increase in backlog to $53.3 million, representing 250% of Q3 revenue, and a customer base that more than doubled over the past year. The company's contracted capacity supports its growth outlook, with management indicating that just $10 million in quarterly revenue growth could lead to profitability. Tailwinds from expanding SKUs, new markets, and verticals are expected to drive triple-digit growth into 2026. Analyst sentiment firmed post-earnings, with two reaffirmed Buy ratings and increased price targets averaging $16, above the $13.25 consensus. Institutional ownership, though currently at 5%, has shown bullish accumulation for four consecutive quarters, suggesting growing confidence. While the balance sheet shows over $70 million in cash and zero debt, a 14% increase in share count due to capital raises is noted, though offset by equity gains.